Related Experiment Video
Updated: Sep 21, 2025
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
A role for microfluidic systems in precision medicine
Jose M Ayuso1,2,3, María Virumbrales-Muñoz2,3, Joshua M Lang3,4
1Department of Dermatology, University of Wisconsin, Madison, WI, USA.
Abstract:
Precision oncology continues to challenge the "one-size-fits-all" dogma. Under the precision oncology banner, cancer patients are screened for molecular tumor alterations that predict treatment response, ideally leading to optimal treatments. Functional assays that directly evaluate treatment efficacy on the patient's cells offer an alternative and complementary tool to improve the accuracy of precision oncology. Unfortunately, traditional Petri dish-based assays overlook much tumor complexity, limiting their potential as predictive functional biomarkers. Here, we review past applications of microfluidic systems for precision medicine and discuss the present and potential future role of functional microfluidic assays as treatment predictors.
Insights
Functional microfluidic assays offer a more accurate way to predict cancer treatment response by analyzing patient cells. These advanced methods overcome limitations of traditional assays for better precision oncology outcomes.
Area of Science:
- Oncology
- Biomedical Engineering
- Translational Medicine
Background:
- Precision oncology aims to personalize cancer treatment based on molecular tumor profiles.
- Current methods often rely on molecular alterations, but functional assays offer complementary predictive power.
- Traditional functional assays using Petri dishes fail to capture tumor complexity, limiting their utility.
Purpose of the Study:
- To review the application of microfluidic systems in precision medicine.
- To discuss the current and future role of functional microfluidic assays in predicting cancer treatment efficacy.
- To highlight microfluidic assays as a tool to enhance precision oncology.
Main Methods:
- Review of existing literature on microfluidic systems in precision medicine.
- Analysis of functional microfluidic assay designs and their application in cancer research.
- Discussion of the advantages of microfluidic platforms over traditional cell-based assays.
Main Results:
- Microfluidic systems have been applied in various aspects of precision medicine.
- Functional microfluidic assays can better mimic the tumor microenvironment, providing more accurate treatment response predictions.
- These assays address the limitations of conventional methods by incorporating tumor complexity.
Conclusions:
- Functional microfluidic assays represent a promising advancement for precision oncology.
- They offer a more accurate and reliable method for predicting patient-specific treatment responses.
- The continued development of microfluidic technology will enhance their role as predictive biomarkers in cancer care.
